C Soubrouillard

457 total citations
8 papers, 360 citations indexed

About

C Soubrouillard is a scholar working on Neurology, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, C Soubrouillard has authored 8 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 3 papers in Cognitive Neuroscience and 2 papers in Experimental and Cognitive Psychology. Recurrent topics in C Soubrouillard's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Neurological disorders and treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). C Soubrouillard is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Neurological disorders and treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). C Soubrouillard collaborates with scholars based in France, United States and Belgium. C Soubrouillard's co-authors include Olivier Blin, Stephen Wright, Olivier Rascol, Nelly Fabre, Claire Thalamas, John G. Nutt, Joëlle Micallef, Joel M. Trugman, Christopher G. Goetz and L. J. Currie and has published in prestigious journals such as Annals of Neurology, Behavioural Brain Research and Human Psychopharmacology Clinical and Experimental.

In The Last Decade

C Soubrouillard

8 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Soubrouillard France 6 207 162 69 63 43 8 360
Janet Sangare United States 7 103 0.5× 216 1.3× 86 1.2× 106 1.7× 28 0.7× 10 408
T. Br�cke Austria 8 255 1.2× 304 1.9× 64 0.9× 74 1.2× 21 0.5× 9 546
Patrizia Ferrero Italy 9 90 0.4× 138 0.9× 88 1.3× 23 0.4× 52 1.2× 17 336
Verónica Paz Spain 9 110 0.5× 134 0.8× 96 1.4× 33 0.5× 31 0.7× 28 324
Thea P. Lillethorup Denmark 11 191 0.9× 150 0.9× 48 0.7× 35 0.6× 109 2.5× 18 356
Gary Wisniewski United States 6 144 0.7× 309 1.9× 90 1.3× 65 1.0× 25 0.6× 9 470
Joanna Ekström Sweden 3 55 0.3× 238 1.5× 111 1.6× 114 1.8× 27 0.6× 6 386
Hannah Furby United Kingdom 11 89 0.4× 152 0.9× 120 1.7× 57 0.9× 41 1.0× 16 388
George Carr Canada 6 101 0.5× 202 1.2× 76 1.1× 89 1.4× 58 1.3× 7 350
Heiko Huber Germany 10 225 1.1× 153 0.9× 64 0.9× 111 1.8× 57 1.3× 12 450

Countries citing papers authored by C Soubrouillard

Since Specialization
Citations

This map shows the geographic impact of C Soubrouillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Soubrouillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Soubrouillard more than expected).

Fields of papers citing papers by C Soubrouillard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Soubrouillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Soubrouillard. The network helps show where C Soubrouillard may publish in the future.

Co-authorship network of co-authors of C Soubrouillard

This figure shows the co-authorship network connecting the top 25 collaborators of C Soubrouillard. A scholar is included among the top collaborators of C Soubrouillard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Soubrouillard. C Soubrouillard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kilani, M., Joëlle Micallef, C Soubrouillard, et al.. (2004). A longitudinal study of the evolution of cognitive function and affective state in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 5(1). 46–54. 77 indexed citations
2.
Tardieu, Sophie, C Soubrouillard, Christine Alquier, et al.. (2004). A randomized clinical trial comparing doses and efficacy of lormetazepam tablets or oral solution for insomnia in a general practice setting. Human Psychopharmacology Clinical and Experimental. 19(2). 129–134. 5 indexed citations
3.
Micallef, Joëlle, et al.. (2001). A double blind parallel group placebo controlled comparison of sedative and amnesic effects of etifoxine and lorazepam in healthy subjects. Fundamental and Clinical Pharmacology. 15(3). 209–216. 49 indexed citations
4.
Rascol, Olivier, John G. Nutt, Olivier Blin, et al.. (2001). Induction by Dopamine D1 Receptor Agonist ABT-431 of Dyskinesia Similar to Levodopa in Patients With Parkinson Disease. Archives of Neurology. 58(2). 249–249. 113 indexed citations
5.
Masson, Guillaume S., et al.. (2000). Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factors. Behavioural Brain Research. 108(2). 169–180. 28 indexed citations
6.
Rascol, Olivier, Olivier Blin, Claire Thalamas, et al.. (1999). ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease. Annals of Neurology. 45(6). 736–741. 86 indexed citations
7.
Soubrouillard, C, et al.. (1998). [Central dopaminergic D1 agonists and treatment of Parkinson disease].. PubMed. 52(6). 527–34. 1 indexed citations
8.
Guise, Sylvain De, C Soubrouillard, & Olivier Blin. (1997). [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].. PubMed. 23 Spec No 2. 10–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026